Cancer Target Collaboration Agreement Signed Between MedImmune and Georgetown University
28-Sep-2005 -
MedImmune, Inc. announced that it has entered into a licensing and collaboration agreement with Georgetown University for the development of monoclonal antibodies (MAbs) targeting anaplastic lymphoma kinase (ALK), a member of the insulin receptor family of tyrosine kinases. ALK is believed to ...
insulin
kinases
lung cancer
+6